نتایج جستجو برای: s1p receptor

تعداد نتایج: 591328  

Journal: :research in molecular medicine 0
ebrahim banitalebi assistant professor in exercise physiology, university of shahrekord. shahrekord. iran reza gharakhanlou 2- associate professor in exercise physiology, department of sport sciences, tarbiat modares university, tehran, iran.

background: the purpose of present study was to investigate whether sphingosine 1-phosphate (s1p) levels and its receptors gene expressions are correlated with myod and myogenin following resistance training. materials and methods: 24 eight-week-old male wistar rats (190-250 gr) were assigned randomly to a control (n = 12) or training (n = 12) group. rats climbed a resistance training ladder wi...

Objective(s):Degradation of sphingosine 1-phosphate (S1P), as a bioactive lipid, or deregulation of its production involves in tumor progression, metastasis and chemoresistance. Since the tumor progression effects of S1P and its mechanism in chronic lymphoblastic leukemia and non-small cell lung cancer is not fully understood, we investigated the role and one of the mechanisms of S1P in tumor p...

Journal: :American journal of physiology. Heart and circulatory physiology 2007
Christopher K Means Chun-Yang Xiao Zhuangjie Li Tong Zhang Jeffrey H Omens Isao Ishii Jerold Chun Joan Heller Brown

Sphingosine 1-phosphate (S1P) is released at sites of tissue injury and effects cellular responses through activation of G protein-coupled receptors. The role of S1P in regulating cardiomyocyte survival following in vivo myocardial ischemia-reperfusion (I/R) injury was examined by using mice in which specific S1P receptor subtypes were deleted. Mice lacking either S1P(2) or S1P(3) receptors and...

Journal: :The Journal of biological chemistry 2008
Christopher Kable Means Shigeki Miyamoto Jerold Chun Joan Heller Brown

Adult mouse ventricular myocytes express S1P(1), S1P(2), and S1P(3) receptors. S1P activates Akt and ERK in adult mouse ventricular myocytes through a pertussis toxin-sensitive (G(i/o)-mediated) pathway. Akt and ERK activation by S1P are reduced approximately 30% in S1P(3) and 60% in S1P(2) receptor knock-out myocytes. With combined S1P(2,3) receptor deletion, activation of Akt is abolished and...

Journal: :International Journal of Molecular Sciences 2019

Journal: :iranian journal of basic medical sciences 0
maryam tabasinezhad research center for pharmaceutical nanotechnology, tabriz university of medical sciences, tabriz, iran department of medical biotechnology, faculty of advanced medical sciences, tabriz university of medical sciences, tabriz, iran student research center committee, tabriz university of medical sciences, tabriz, iran hamid ghaedi medical genetics department, faculty of medicine, shahid beheshti university of medical sciences, tehran, iran parisa qanbari research center for pharmaceutical nanotechnology, tabriz university of medical sciences, tabriz, iran department of medical biotechnology, faculty of advanced medical sciences, tabriz university of medical sciences, tabriz, iran mahsa mohseni research center for pharmaceutical nanotechnology, tabriz university of medical sciences, tabriz, iran department of medical biotechnology, faculty of advanced medical sciences, tabriz university of medical sciences, tabriz, iran mehdi sabzichi research center for pharmaceutical nanotechnology, tabriz university of medical sciences, tabriz, iran department of medical biotechnology, faculty of advanced medical sciences, tabriz university of medical sciences, tabriz, iran nasser samadi research center for pharmaceutical nanotechnology, tabriz university of medical sciences, tabriz, iran department of medical biotechnology, faculty of advanced medical sciences, tabriz university of medical sciences, tabriz, iran

objective(s):degradation of sphingosine 1-phosphate (s1p), as a bioactive lipid, or deregulation of its production involves in tumor progression, metastasis and chemoresistance. since the tumor progression effects of s1p and its mechanism in chronic lymphoblastic leukemia and non-small cell lung cancer is not fully understood, we investigated the role and one of the mechanisms of s1p in tumor p...

Journal: :Molecular pharmacology 2010
Akira Murakami Hiroshi Takasugi Shinya Ohnuma Yuuki Koide Atsuko Sakurai Satoshi Takeda Takeshi Hasegawa Jun Sasamori Takashi Konno Kenji Hayashi Yoshiaki Watanabe Koji Mori Yoshimichi Sato Atsuo Takahashi Naoki Mochizuki Nobuyuki Takakura

Sphingosine 1-phosphate (S1P) induces diverse biological responses in various tissues by activating specific G protein-coupled receptors (S1P(1)-S1P(5) receptors). The biological signaling regulated by S1P(3) receptor has not been fully elucidated because of the lack of an S1P(3) receptor-specific antagonist or agonist. We developed a novel S1P(3) receptor antagonist, 1-(4-chlorophenylhydrazono...

Journal: :The Biochemical journal 2001
K Tamama J Kon K Sato H Tomura A Kuwabara T Kimura T Kanda H Ohta M Ui I Kobayashi F Okajima

Exogenous sphingosine 1-phosphate (S1P) increased cytosolic Ca(2+) concentration, stimulated thymidine incorporation (DNA synthesis) and inhibited cell migration in rat aortic smooth-muscle cells (AoSMCs). Although exogenous sphingosine, a substrate of sphingosine kinase or a precursor of S1P, markedly induced the intracellular accumulation of S1P, the lipid failed to mimic the S1P-induced acti...

Journal: :The Journal of biological chemistry 2004
M Germana Sanna Jiayu Liao Euijung Jo Christopher Alfonso Min-Young Ahn Melissa S Peterson Bill Webb Sophie Lefebvre Jerold Chun Nathanael Gray Hugh Rosen

Sphingosine 1-phosphate (S1P) influences heart rate, coronary artery caliber, endothelial integrity, and lymphocyte recirculation through five related high affinity G-protein-coupled receptors. Inhibition of lymphocyte recirculation by non-selective S1P receptor agonists produces clinical immunosuppression preventing transplant rejection but is associated with transient bradycardia. Understandi...

Journal: :British journal of pharmacology 2008
S Salomone E M Potts S Tyndall P C Ip J Chun V Brinkmann C Waeber

BACKGROUND AND PURPOSE Sphingosine 1-phosphate (S1P) selectively and potently constricts isolated cerebral arteries, but this response has not been pharmacologically characterized. EXPERIMENTAL APPROACH The receptor subtype(s) involved in S1P-induced cerebrovascular constriction were characterized using genetic (S1P(2) and S1P(3) receptor null mice) and pharmacological tools (phospho-FTY720, ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید